-
Views
-
Cite
Cite
P. Altucci, G. F. Abbate, I. Alagia, V. Leonessa, Clinical Evaluation of Tobramycin in Respiratory and Systemic Infections in Immunodepressed and Normal Patients, The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S182–S186, https://doi.org/10.1093/infdis/134.Supplement_1.S182
- Share Icon Share
Abstract
Twelve patients with acute or chronic pneumonia due mainly to gram-negative bacilli, two patients with pseudomonas endocarditis, and two patients with serratia sepsis were treated with 80–160 mg of tobramycin in two daily doses. Fourteen infected patients with underlying leukemia or lymphoma received this dose of tobramycin combined with cefazolin or penicillin. Most respiratory infections were cured or markedly improved, with eradication or significant reduction in the number of infecting organisms. One case of pseudomonas endocarditis and both cases of serratia sepsis were also cured. Combined treatment with tobramycin and β-lactam antibiotics resulted in clinical and bacteriological improvement in 50% of systemic immunodepressed patients with sepsis and/or pneumonia.